Photo by Sam Moqadam on Unsplash
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Gareth Sheridan, CEO of Nutriband (NASDAQ:NTRB), was a guest speaker on Benzinga’s All Access Events on February 4th, 2022.
He discussed how Nurtriband, by focusing exclusively on transdermal solutions, fills in an important gap in the pharmaceutical market.
Watch the full interview here.
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
